Conferences and Meetings on Oncology

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
Breast Cancer Conference — The 9th Annual Royal Marsden Breast Cancer Meeting: Hot Topics in Breast Cancer
ID
805567
Dates
07 Oct 1201 - 07 Oct 2016
Location
Regents Park, London, United Kingdom
Abstract
The Royal Marsden NHS Foundation Trust is holding its 9th Annual Breast Cancer Meeting on Friday 7th October 2016. As in previous years, we aim to provide an update on what is new, challenging and controversial in the management of patients with breast cancer. This year we will address some dilemmas during neo-adjuvant therapy including imaging techniques and surgical management of the axilla. We will discuss some of the common questions that patients ask, namely who needs genetic testing nowadays and what diet should be followed, in addition to providing an update on molecular testing and emerging novel therapies.
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Clinical Dilemmas in Breast Cancer Management, Imaging Pre & Post Neo-adjuvant Therapy, Which patients need Genetic Testing?, What Dietary Advice to give my patient?, Panel Discussion, Advances in Diagnostics and Novel Therapies, Molecular Profiling – what do I need to know?, New drugs for MBC – hype or real progress?, Cridlan Lecture & MDT, Advances in Radiation Therapy for Early Breast Cancer, Questions/Discussion, MDT Cases, Presentation, Discussion and Debate, MDT Cases, Presentation and Debate.
2.
 
IASGO 2016 — The 26th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists
ID
798139
Dates
08 Sep 2016 - 08 Oct 2016
Location
Seoul, South Korea
Abstract
The 26th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO 2016 ) will be held from September 8 (Thursday) to 10 (Saturday), 2016, at the Sheraton Grande Walkerhill Hotel in Seoul, Korea. Hosted International Association of Surgeons, Gastroenterologists and Oncologists ; and hosted locally by Korean Society of Surgical Oncology and Korean Society of Gastrointestinal Cancer; the official congress program will include Keynote Lecture, Symposia, and Oral Session with Opening/Closing Ceremonies, Welcome Reception, and Networking Dinner among the Social Events. The official congress languages will be English.
Contact
Congress Secretariat;     Phone: [82-2-566-6033];     Email: seoul@iasgo2016.org
Related subject(s)
Event website
3.
 
NATCON IASO 2016 — 30th Annual National Conference of Indian Association of Surgical Oncology
ID
814693
Dates
22 Sep 2016 - 25 Sep 2016
Location
Jodhpur, India
Abstract
Theme of the conference is
Contact
Dr Virendra Rajpurohit;     Phone: [+91 9829006570];     Email: drvirendra@gmail.com
Topics
Head & Neck, Breast, Thoracic, Gastrointestinal, Hepatopancreaticobiliary, Gynecologic, Genitourinary, Endocrine, Pediatric, Soft Tissue Malignancies.
Related subject(s)
4.
 
World Cancer 2016, London — 12th World Cancer Conference
ID
810510
Dates
26 Sep 2016 - 28 Sep 2016
Location
London, United Kingdom
Abstract
12th World Cancer Conference invites all Oncologists, Radiologists, Cancer Researchers, Pharmacists, Nurses, Scientists, Business Delegates, aspiring Students and Young Researchers to be a part of its global convention at London, UK during September 26-28, 2016. The theme of the conference is around “Integrating every bit of cancer research: Prevention, diagnosis and cure
Contact
Keithi Mayer;     Email: worldcancer@oncologymeet.com
Topics
Cancer, Organ Specific Cancers, Cancer Diagnosis, Cancer Therapy and Treatments, Cancer Drugs, Hemato-Oncology Alternative Medicine and Cancer, Surgical Oncology, Stem Cell Research, Neuro-Oncology, Radiation Oncology, Causes and Prevention, Paediatric Oncology, Cancer Prognosis and Awareness Molecular & Cellular Oncology, Primary Care & Oncology Nursing, Cancer Vaccines, Cancer Nanotechnology Cancer & Lifestyle, Gynaecology Oncology, Cancer Metastasis, Biomarkers Cancer: Psychological & Social Aspects, Cancer Diagnostic Market, Cancer Pharma Industry
Related subject(s)
5.
 
BCC2016 — Breast Cancer Conference 2016
ID
811168
Dates
29 Sep 2016 - 01 Oct 2016
Location
Kuwait, Kuwait
Abstract
In this prestigious occasion we will meet experts from Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA in the field of breast cancer, mainly radiology, to share their expertise and to promote evidence based practice among radiologists, general surgeons, surgical oncologists, medical oncologists, radiotherapist, family physicians, and mammography radiographers as well as other professionals working with breast cancer.
Contact
Basil Kadara;     Phone: [97144532975];     Email: contact@diaedu.com
Topics
Breast Cancer, Radiologists, Surgeons. Mammography, Oncology, Radiotherapy, Cancer
Related subject(s)
Event website
6.
 
2nd EACR Conference on Goodbye Flat Biology: Models, Mechanisms and Microenvironment
ID
798026
Dates
02 Oct 2016 - 05 Oct 2016
Location
Berlin, Germany
Abstract
After the success of the first ‘Goodbye Flat Biology’ meeting in 2014, the EACR is delighted to announce the second conference in the series: ‘Goodbye Flat Biology: Models, Mechanisms and Microenvironment’. This conference will focus on the applications of state-of-the-art 3D culture and tissue engineering technologies to address specific scientific questions ranging from basic tumour biology to more preclinical and translational research.
Contact
Roger Doxat-Pratt;     Email: Roger.Doxat-Pratt@nottingham.ac.uk
Topics
3D; co-culture models; Organoids; Tumour; tumor; Stem cells; ECM biology; Cell signalling; Tissue engineering; Mechano-biology; heterogeneity; screening
7.
 
Paediatric Cytotoxic Medication — Introduction to Pardiatric Cytotoxic Medication
ID
805576
Start date
04 Oct 2016
Location
South Kensington, London, United Kingdom
Abstract
Participants will gain an understanding of the nursing care needs of patients (particularly paediatrics) undergoing treatment with cytotoxic medication.
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Topics covered will include:Explain the action of cytotoxic medication, Demonstrate a basic knowledge of the side effects and nursing implications of cytotoxic medication terms of preparation, assessment and monitoring of patients; Contribute to the assessment of information and support needs of children and their families; Access further information regarding cytotoxic medication, Assist in maintaining a safe environment when cytotoxic medication is being given, Complete the Pan London Cancer Network Cytotoxic Chemotherapy Workbook 1, Information about Preparation for workbook 2 for your clinical area
Related subject(s)
8.
 
Training — Oncology Trials: Focus on Phase III
ID
791222
Dates
05 Oct 2016 - 06 Oct 2016
Location
London, United Kingdom
Abstract
This interactive and informative course provides a comprehensive overview of the planning and implementation of oncology clinical trials, focusing on Phase III. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates can learn to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage. Delegates will hear the perspective of currently practicing oncologists with extensive experience of industry clinical trials as well as professionals who will discuss oncology clinical trial statistics and oncology product market entry.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
Why Are Cancer Trials Different?, Introduction to oncology clinical trial design, Translational Studies in Phase III Trials, Designing Clinical Trials to Impact on Clinical Practice, Statistical analysis and reporting of clinical trials, Quality of life assessment, Other Methods Used for Statistics in Clinical Trials, Planning for Market Access
Related subject(s)
9.
 
DGNR 2016 — 51. Jahrestagung der Deutschen Gesellschaft für Neuroradiologie e.V.
ID
808373
Dates
05 Oct 2016 - 08 Oct 2016
Location
Cologne, Germany
Contact
Deutsche Gesellschaft für Neuroradiologie e.V.;     Phone: [030 916070-70];     Email: dgnr@neuroradiologie.de
Topics
•Degenerative Neuro-Erkrankungen, •Epilepsie, •Onkologie, •Interventionelle Neuroradiologie, •Schlaganfalltherapie
Related subject(s)
Event website
10.
 
ESMO 2016 Congress
ID
760809
Dates
07 Oct 2016 - 11 Oct 2016
Location
Copenhagen, Denmark
Abstract
The annual ESMO Congress is the premier scientific platform to present your oncology research and as such, the ultimate learning experience for Congress attendees. Across disciplines and across cultures, ESMO bridges the gap between researchers, clinicians and patients and unites all stakeholders focused on finding the most effective cancer treatment solutions available today.
11.
 
Lipids, Nanotechnology and Cancer
ID
830023
Dates
10 Oct 2016 - 12 Oct 2016
Location
Tours, France
Abstract
Disorders in lipid metabolism have now been implicated in the development of many diseases including cancer and cardiovascular diseases. At this stage, the metabolism and function of lipids are poorly understood in part due to the complexities of lipid metabolism regulation. While the role of cholesterol and other lipids has been evident for many years in cardiovascular diseases, their role in cancer development and progression is now beginning to be elucidated. Interestingly, drugs that are used to treat lipid metabolic disorders may show their usefulness for the treatment of cancer. Importantly, new research in drug development suggests that lipid metabolism may be used as a target for the treatment of cancer. This new approach will include the use of biopharmaceuticals and nanotechnologies.
Topics
lipid, cholesterol, biopharmaceutical, nanotechnologies, ARD 2020,
12.
 
Palliative Care — The Royal Marsden Palliative Care Update Day
ID
805592
Start date
12 Oct 2016
Location
South Kensington, London, United Kingdom
Abstract
Healthcare professionals with particular interest in caring for the patient with palliative care needs and staff working in areas that place particular emphasis on end of life issues/palliative care.
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Management of complex pain; Complementary therapies in palliative care; Complementary therapies in palliative care, An innovative integrated model of care for nursing homes, Ethical issues in palliative care, Supporting children facing bereavement, Palliative care in interstitial lung disease, Enhanced supportive care: modernising palliative care in cancer, How do you know bad really is ‘bad’..…Prognostic discussions in advanced sarcoma
Related subject(s)
13.
 
IFHNOS Delhi 2016 & FHNO 2016
ID
833617
Dates
12 Oct 2016 - 15 Oct 2016
Location
New Delhi, India
Abstract
A meeting like no other, The Global CME of the International Federation of Head-Neck Societies (IFHNOS), is coming to our doorstep at New Delhi. Do not miss the opportunity to connect to the Global who’s- who in the subject and to partake of this most comprehensive, evidence based, multidisciplinary, and very current educational meeting. The Annual Meetings of the Foundation for Head-Neck Oncology ( FHNO) have already set very high standards in terms of both educational activities and innovative social events. The FHNO represents Indian Head-Neck professionals from India and is among the largest and most vibrant of Head-Neck Societies which constitute the IFHNOS. Head-Neck Cancer unfortunately is among the most common cancers in the Indian subcontinent and the FHNO has been at the forefront of educational and advocacy activities in this realm.
Contact
Dr. Kapil Sikka;     Phone: [+91 9810423088];     Email: secretariat@fhno2016.org
Topics
Head & Neck, cancer, ENT, Otolaryngology,
Related subject(s)
Event website
14.
 
UCC — 8th Annual UAE Cancer Congress
ID
806516
Dates
20 Oct 2016 - 22 Oct 2016
Location
Dubai, United Arab Emirates
Abstract
In 2016, 8th edition of the annual congress will focus on multidisciplinary tracks, offering an academic programme that caters to all specialties involved in the management of patients with cancer. The congress has developed a reputation for providing the most innovative techniques in this critical field of research and knowledge.
Contact
Kris Olarte;     Phone: [+97143116300];     Email: kris.olarte@mci-group.com
Topics
UAECancerCongress, Cancer, Oncology, CancerConference,
15.
 
FFCC — 28th Annual Fall Foliage Cancer Conference
ID
825146
Dates
21 Oct 2016 - 22 Oct 2016
Location
Asheville, NC, United States
Abstract
Two day live activity held at the Omni Grove Park Inn, Asheville, NC
Contact
Nancy Robinson;     Phone: [828-277-9706];     Email: sha@shallc.net
Topics
Melanoma Genetics, Melanoma Surgery in the Era of Effective Systemic Therapies, Immunotherapeutic Advaces in Melanoma, High Dose Radiation with Immunotherapy, Stereotatic Body Radiation Therapy for LIver Metastases, Lynch Syndrome Screening, New Therapies in Gastrointestinal Cancer, Chemoradiation in Treating Gastroesphageal Junction Cancer, Anti PD Therapies in Gastrointestinal Cancer
Event website
16.
 
Hematologic Cancers - An Introduction
ID
814735
Dates
25 Oct 2016 - 26 Oct 2016
Location
Newark, NJ, United States
Abstract
This course reviews the hematological system and provides and overview on the spectrum of hematological cancers. The pathophysiology of hematological malignancies such as leukemia’s, lymphomas and myeloma are discussed along with their common treatments. The issues and complications of bone marrow and stem cell transplant will be reviewed. Matters relating to clinical trials including ethical considerations and FDA directives will be examined. This high caliber training program led by teams of specialist physicians, it is ideal for the pharmaceutical, medical technology and biotechnology industries. Case studies and open discussion form an integral part of the program.

Topics include:

- The formation and maturation of blood cells

- Classification and epidemiology of hematological malignancies

- Presentations, diagnosis and staging

- Chemotherapy and irradiation

- Clinical trial issues

Contact
James Prudhomme;     Phone: [781-972-5400];     Email: jprudhomme@healthtech.com
Topics
hematology, hematologic cancers, hematological malignancies, cancer, leukemia, lymphoma, myelome
Related subject(s)
17.
 
CME River Cruise - Rhine Getaway Featuring Contemporary Multidisciplinary Management of Breast Cancer
ID
807778
Dates
26 Oct 2016 - 02 Nov 2016
Location
Cologne, Germany
18.
 
SWGIM 2016 — 53. Kongress der Südwestdeutschen Gesellschaft für Innere Medizin
ID
811853
Dates
28 Oct 2016 - 29 Oct 2016
Location
Karlsruhe, Germany
Contact
Lisa Dinter;     Phone: [+49 3643 2468-147];     Email: lisa.dinter@kukm.de
19.
 
JADPRO Live at APSHO: United in Practice. United in Care.
ID
812589
Dates
03 Nov 2016 - 06 Nov 2016
Location
Washington, DC, United States
Abstract
APSHO's mission is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology. CE-accredited educational sessions for physicians, nurses, pharmacists, nurse practitioners and physician assistants will be presented throughout the conference which will include didactic, interactive, evidence-based and fair-balanced content targeted to the advanced practitioners (APs) in oncology. Advanced practitioners and physicians will come together in a team setting to discuss current treatment options and advances in the care of the patient with cancer, describe key practice initiatives that are essential to the AP, and identify means to improve collaboration--all with an ultimate goal of improving patient outcomes and decreasing adverse events.
Contact
Ceil Boyce;     Phone: [609-853-0025];     Email: cboyce@apsho.org
Topics
Oncology, Hematology, Advanced Practitioners, Physicians, Nurses, Nurse Practitioners Physician Assistants, Clinical Nurse Specialists, Advanced Degree Nurses, Pharmacists, ACCME, ANCC, ACPE, didactic, interactive, evidence-based
Related subject(s)
20.
 
Synergy 2016: A Multidisciplinary Approach to Interventional Oncology
ID
823143
Dates
03 Nov 2016 - 06 Nov 2016
Location
Miami Beach, United States
Abstract
This annual symposium offers attendees a review of a variety of oncological diseases combined with the latest developments in medical, interventional and surgical therapeutic options across multiple disciplines. A practical overview of how to incorporate emerging therapies into practice will be included with emphasis on the multidisciplinary approach needed to achieve the highest levels of success in the fight against cancer. Leading experts from national and international programs will present the latest data and treatment innovations for oncological challenges in multiple organ systems with emphasis on implementation from diagnosis to treatment. A multidisciplinary symposium on prostate interventions (PAE) offers a comprehensive review on emerging topics and various aspects of prostate artery embolization, combined with the latest developments in medical, surgical and interventional management of benign prostatic hyperplasia and prostate cancer. The course will include dedicated Hands-On workshops on Ablation and Embolization. The meeting will be didactic and interactive with panel discussions and instructive case presentations focused on hepatocellular carcinoma, lung cancer, metastatic colorectal cancer, cholangiocarcinoma and liver metastases, renal and prostate cancer, pancreatic cancer, neuroendocrine, musculoskeletal tumors and palliative treatment options. A daily Nursing Symposium will also be offered during the meeting.
Contact
University of Miami CME;     Phone: [(305) 243-6716];     Email: cme@med.miami.edu
Topics
Interventional, Cancer, Oncology, Prostate, Carcinoma, Hepatology, Urology, Radiology, CME, Surgery, Workshop, Tumors, Pancreatic, PAE, Embolization, Symposium, Conference, Miami, Florida, Nursing, Ablation, Synergy
21.
 
Hämato/Onko Refresher, Berlin
ID
786430
Dates
04 Nov 2016 - 05 Nov 2016
Location
Adlershof con.vent. - Veranstaltungszentrum (Bunse, Germany
Contact
Christin Rasper;     Phone: [+49 (0) 6192 957 89 -41];     Email: info@fomf.de
Topics
Refresher, Hämatologie, Onkologie, Fortbildung
Related subject(s)
Event website
22.
 
BTMC — Novel Concepts in the Biology and Treatment of Metastatic Cancer Conference
ID
796243
Dates
05 Nov 2016 - 08 Nov 2016
Location
Paphos, Cyprus
Abstract
Metastatic disease, the lethal component of cancer, remains largely intractable to modern medicine. New insights into the biology of metastasis promise fresh insights into how to design therapies that effectively tackle this life-threatening disease process. Recent years have seen the development of novel tools for studying metastasis that continue to provide dramatic advances in our understanding of the cellular and molecular mechanisms that drive metastasis formation. Metastasis is regulated by both tumor cell-intrinisic factors such as genetic defects, epigenetic perturbation and metabolic changes, as well as by a variety of factors in the microenvironment, including cells of the immune system. These tumor cell-intrinsic factors combine with the external microenvironment to regulate tumor dormancy and the development of therapy resistance. This knowledge is starting to be translated into therapies that target not only the metastatic seed but also the microenvironmental soil.
Contact
Laura Trundle;     Phone: [+44 (0)1638 724137];     Email: laura@fusion-conferences.com
Topics
Key sessions include; therapy-induced metastasis and the patient with metastatic disease, metabolic changes that drive metastasis, metastatic dormancy - maintenance and escape, regulation of metastasis via epigenetics/non-coding RNAs and chromatin modification, novel approaches to pharmacology and drug delivery for the treatment of metastases, control of metastasis by inflammation and the innate immune system, targeting the metastatic microenvironment, novel tools for studying metastasis and cancer stem cells.
23.
 
2nd Cancer Diagnostics
ID
829925
Dates
07 Nov 2016 - 08 Nov 2016
Location
San Francisco, United States
Abstract
We invite you to attend the Cancer Diagnostics Conference, which will take place November 7-8, 2016 in San Francisco, CA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss new research in cancer diagnostics, including next generation sequencing, the use of clinical utility of cell-free DNA liquid biopsy, patient selection for cancer drug development, and correlative predictive markers.
Contact
Nicholas Rodriguez;     Phone: [+16262566405];     Email: infogtcbio@gtcbio.com
24.
 
Cancer Immunotherapy
ID
829957
Dates
07 Nov 2016 - 08 Nov 2016
Location
San Francisco, United States
Abstract
The field of Cancer Immunotherapy is of continuously escalating significance, as well as scientifically, economically and socially important. The Cancer Immunotherapy Conference on November 7-8, 2016 in San Francisco, CA allows scientists, clinicians, and R&D experts to meet together and discuss the latest therapeutic, preventive and diagnostic developments in the field.
Contact
Nicholas Rodriguez;     Phone: [+16262566405];     Email: infogtcbio@gtcbio.com
25.
 
FCS 2016 — Frontiers in Cancer Science 2016
ID
818106
Dates
07 Nov 2016 - 09 Nov 2016
Location
Singapore, Singapore
Abstract
Returning for the 8th year, Frontiers in Cancer Science (FCS) 2016 promises to deliver an impressive scientific program packed with renowned researchers and scientists from over the world. Jointly organized by Cancer Science Institute of Singapore, Duke-NUS Graduate Medical School, Institute of Molecular and Cell Biology, Lee Kong Chian School of Medicine, National Cancer Centre Singapore and National University Cancer Institute, Singapore, FCS 2016 converges the latest cancer discoveries around the world. This meeting promises ground breaking and innovative insights into cancer research. Join us now!
Contact
Conference Secretariat;     Email: csi_singapore@nus.edu.sg
Related subject(s)
26.
 
Novel Cancer Therapeutics Summit 2016
ID
829840
Dates
07 Nov 2016 - 09 Nov 2016
Location
San Francisco, United States
Abstract
This summit will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials working to identify and exploit advances in the field of oncology in order to deliver products with a meaningful clinical impact. In addition, industry leaders from big pharma and various biotech/pharmaceutical companies, including business/corporate development executives, licensing executives, global alliance, and venture capitalists, will all be present to explore potential collaborations and learn about relevant issues in oncology.
Contact
Nicholas Rodriguez;     Phone: [+16262566405];     Email: infogtcbio@gtcbio.com
27.
 
5th Cancer Epigenetics
ID
829927
Dates
08 Nov 2016 - 09 Nov 2016
Location
San Francisco, United States
Abstract
Lately the field of epigenetics has been rapidly changing and progressing. Advances that were made possible because of the Human Genome Project have opened up new possibilities about how epigenetics can be used to stop cancer. Scientists have recently discovered that there are potentially two sets of enzymes that are responsible for regulating the chemical structure of chromatin, which consists of the methyl and acetyl marks in the chromatin structure. Theoretically, by changing and controlling the chromatin structure, scientists can attempt to gain epigenetic control of DNA in order to potentially stop aberrant gene expression.
Contact
Nicholas Rodriguez;     Phone: [+16262566405];     Email: infogtcbio@gtcbio.com
28.
 
5th Oncology Partnering & Deal-Making
ID
829893
Dates
08 Nov 2016 - 09 Nov 2016
Location
San Francisco, United States
Abstract
We invite you to attend the 5th Oncology Partnering & Deal-Making Conference, which will take place November 8-9, 2016 in San Francisco, CA. This event is a partnership and business development conference that provides an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant issues in oncology that will affect the industry.
Contact
Nicholas Rodriguez;     Phone: [+16262566405];     Email: infogtcbio@gtcbio.com
29.
 
EVK Workshop 2016 — Endoskopie Workshop EVK Düsseldorf 2016
ID
811214
Start date
09 Nov 2016
Location
Düsseldorf, Germany
Contact
Frau Sandra Reber;     Phone: [089/8906770];     Email: sandra.reber@cocs.de
Topics
- Live Übertragungen aus der Abteilung für Endoskopie- Detektion und Therapie der frühen Barrett Neoplasie- Moderne Endoskopie bei Erkrankungen des Dünndarms- Interdisziplinäre Diagnostik und Therapie zystischer Tumore des Pankreas
Related subject(s)
30.
 
Gynaecological Oncology — An Update on Topical Issues within Gynaecology Oncology
ID
805553
Start date
09 Nov 2016
Location
South Kensington, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Update in Gynaecology Oncology Surgery, Long term GI effects of cancer treatment; Genetics and BRCA testing in Gynaecology Oncology; Update in Gynaecology Clinical Oncology and Nurse led Clinics in Endometrial cancer, A Patient’s perspective, Supporting Women on aspects of motherhood and parenting, Update in Gynaecology Medical Oncology and Nurse led Chemotherapy Clinics, Sexuality post treatment for Gynaecological cancers, Summary and questions session.
31.
 
Introduction to Oncology and Its Treatment
ID
830417
Dates
09 Nov 2016 - 10 Nov 2016
Location
London, United Kingdom
Abstract
Delegates attending this course benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs are reviewed with emphasis on mode of action, dose intensity and chemotherapy regimes. These lead on to a detailed study of the range of side effects of cancer treatments. Quality of life issues in terms of overall assessment and result interpretation are discussed too.   Detailed consideration is given to the treatment of major tumour types; breast, lung, upper gastrointestinal (GI), colorectal, skin cancer, ovarian and prostate cancer.
32.
 
Cancer Metabolism and the Tumour Microenvironment Conference
ID
799940
Dates
09 Nov 2016 - 12 Nov 2016
Location
Pafos, Cyprus
Abstract
This meeting will bring together diverse researchers from the fields of cancer metabolism and stromal cell biology, providing an opportunity to discuss recent developments and new areas of cross-fertilization between those fields.
Related subject(s)
33.
 
Head and Neck Cancer Conference — The 8th Royal Marsden Head and Neck Cancer Conference:
ID
805629
Start date
11 Nov 2016
Location
Regents Park, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
The meeting on Friday 11th November 2016 assembles some of the country’s leading experts to critically discuss the evidence base on which the guidelines were developed. Attendees will also be updated on the process of guideline development and the underlying health economics. The meeting will be of particular interest to maxillofacial, ENT or plastic surgeons with an interest in head and neck oncology, as well as clinical / medical oncologists, radiologists and pathologists. Our invitation is extended to consultants and trainees alike, as well as other members of the multidisciplinary team. The meeting will be interactive with ample opportunity to discuss the evidence presented
34.
 
Hämato/Onko Refresher, Köln
ID
786451
Dates
11 Nov 2016 - 12 Nov 2016
Location
KOMED im MediaPark GmbH, Im MediaPark 7, 50670 -, Germany
Contact
Christin Rasper;     Phone: [+49 (0) 6192 957 89 -41];     Email: info@fomf.de
Topics
Refresher, Hämatologie, Onkologie, Fortbildung
Related subject(s)
Event website
35.
 
Sentinel lymph node biopsy in mucosal and cutaneous head and neck cancer — Sentinel lymph node biopsy in mucosal and cutaneous head and neck cancer: why, when and how.
ID
805522
Start date
12 Nov 2016
Location
Regents Park, London, United Kingdom
Abstract
Sentinel lymph node biopsy in mucosal and cutaneous head and neck cancer: why, when and how.
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
There is an additional Event on the previous day, Friday 11th November 2016:The 8th Annual Royal Marsden Head and Neck Conference:This event will focus on the recently published NICE guidelines on upper aerodigestive tract cancer. The meeting assembles some of the country’s leading experts to critically discuss the evidence base on which the guidelines were developed. Attendees will also be updated on the process of guideline development and the underlying health economics. The meeting will be of particular interest to maxillofacial, ENT or plastic surgeons with an interest in head and neck oncology, as well as clinical / medical oncologists, radiologists and pathologists. Our invitation is extended to consultants and trainees alike, as well as other members of the multidisciplinary team. The meeting will be interactive with ample opportunity to discuss the evidence presented.Attendees to both events will be offered discounted fees.Date: Friday - 11th of November 2016 Venue: The Royal College of Physicians, London, NW1 4LE Fee: £180 Full Delegate £120 Trainees and CNSs CPD accreditation applied for from the Royal College of Physicians. Book on the two events at a discounted rate:(£280 Full Delegate / £220 Trainees and CNSs)
36.
 
Molecular and Cellular Basis of Breast Cancer Risk and Prevention
ID
781670
Dates
12 Nov 2016 - 15 Nov 2016
Location
United States, United States
Abstract
The goals for the program are to inspire important insights, energise new scientists and foster creative collaborations that will deepen our understanding of the molecular events underlying breast cancer initiation and accelerate the development of targeted prevention and early detection strategies.
Related subject(s)
37.
 
Fortbildungsveranstaltung — "Leitlinien im Überblick": S3-Leitlinie Supportivtherapie
ID
825716
Start date
16 Nov 2016
Location
Berlin, Germany
Abstract
Die Fortbildungsveranstaltung wird fallbasiert aufgebaut: Von der klinischen Fragestellung zur Schlüsselempfehlung der Leitlinien
Contact
Frau Juliane Truskowski;     Phone: [03643 2468-129 (Büro Weimar)];     Email: juliane.truskowski@ng-akademie.de
Topics
Leitlinien, Onkologie, NGA
38.
 
Advances in prostate cancer diagnosis and treatment
ID
829864
Start date
17 Nov 2016
Location
London, United Kingdom
Abstract
This event, supporting the Movember Foundation, encompasses both an educational day event aimed at medical professionals and an informal evening session for those interested in the patient experience. Delegates may attend one or both of the sessions. The day will highlight new imaging and therapeutic aspects concerning prostate cancer. It is aimed at radiologists, oncologists, urologists, specialty trainees and radiographers but will also be of interest to junior and senior clinicians interested in prostate cancer.
Contact
Rebecca Groves;     Phone: [02036682230];     Email: rebecca.groves@bir.org.uk
Topics
Prostate cancer, Oncology, radiotherapy, diagnosis, cancer treatment
39.
 
EOC2016 — 5th Emirates Oncology Conference 2016
ID
807804
Dates
17 Nov 2016 - 19 Nov 2016
Location
Abu Dhabi, United Arab Emirates
Abstract
The three-day conference will feature international, regional and local experts and workshops in cancer research, treatment and care.

The 5th Emirates Oncology Conference 2016 will host around academics, oncologists, allied health professionals and medical students from the region, in addition to speakers from the UAE, the USA, Europe, and across the Middle East. Thought leaders in various specialties within oncology will discuss the latest treatments and advances and help improve oncology treatment in the UAE and the wider region.

As a medical professional with special interest in oncology, it will be of great benefit for you to participate in our fourth annual conference. Here, you will learn more about the latest developments in oncology with a view to improving regional standards of diagnosis, treatment and care.

Contact
Basil Kadara;     Phone: [+97144532975];     Email: contact@diaedu.com
Topics
Oncology, Breast Cancer
Event website
40.
 
13. AIO-Herbstkongress
ID
799371
Dates
17 Nov 2016 - 19 Nov 2016
Location
Berlin, Germany
Abstract
Vom 17. bis 19. November 2016 findet der 13. AIO-Herbstkongress „Update Medical Oncology“ im Hotel Pullman Berlin Schweizerhof statt. Wie schon in den vergangenen Jahren steht der Kongress ganz im Zeichen der klinischen Forschungsarbeit des Themenbereiches der soliden Tumoren und der Translationalen Forschung. Der AIO-Herbstkongress wird inhaltlich von den Arbeits- und Studiengruppen der AIO gestaltet und befasst sich schwerpunktmäßig mit dem wissenschaftlichen Update dieser Studienaktivitäten. Das Format des AIO-Herbstkongresses mit seinen Plenar- und Gruppensitzungen, Symposien und Diskussionsrunden hat sich bewährt, was nicht zuletzt an den steigenden Teilnehmerzahlen und einer umfangreichen begleitenden Industrieausstellung ersichtlich ist.
Contact
Andreas Kandler;     Phone: [+49 (0)89 54 90 96-77];     Email: aio-herbstkongress@mci-group.com
Related subject(s)
41.
 
Onkologische Gesprächsreihe 2016 — NGA-Winter Gespräche 2016
ID
813128
Dates
18 Nov 2016 - 19 Nov 2016
Location
Tübingen, Germany
Contact
Frau Claudia Holzweißig;     Phone: [03643 2468-123 (Büro Weimar)];     Email: claudia.holzweiszig@ng-akademie.de
42.
 
Haematology — Management Issues in Haematological Disorders in Adults
ID
806415
Start date
21 Nov 2016
Location
South Kensington, London, United Kingdom
Abstract
Healthcare professionals, particularly nursing staff involved in the treatment of these patients and others involved in their care, such as pharmacists and radiologists. We also aim to involve trainee doctors who are preparing for the MRC Path and FRC Path examinations.
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Update on lymphoma treatment, Patient psychology - needs in the haematology setting, Current treatment strategies in myeloma, Progress in the treatment of myelodysplasia, Advances in the treatment of chronic lymphocytic leukaemia, Intensive Care and the haematology patient, Questions.
Related subject(s)
43.
 
Training — Introduction to radiofrequency ablation
ID
829734
Start date
21 Nov 2016
Location
London, United Kingdom
Abstract
Radiofrequency ablation (RFA) is a rapidly developing minimally invasive treatment technique for certain cancers of the lung, liver and kidney. With an ageing population, more patients will present with primary or metastatic disease who may not be suitable surgical candidates. There is, therefore, an increasing need for clinicians and radiologists to learn about RFA and related techniques, which is cheaper than surgery with a shorter length of stay.
Contact
Malini Banerjee;     Phone: [02036682226];     Email: Malini.Banerjee@bir.org.uk
Topics
radiofrequency, ablation, radiology, cancer, treatment, lung, liver, kidney, metastatic, disease, surgery, microwave, cryotherapy, high, intensity, ultrasound, tumour, tumor, non-invasive, imaging
44.
 
Onkologische Gesprächsreihe 2016 — Münchner NGA-Gespräche 2016
ID
834778
Start date
25 Nov 2016
Location
Munich, Germany
Abstract
Der onkologische Patient im Mittelpunkt. Fortbildung für Pflege- und medizinisches Fachpersonal.
Contact
Frau Claudia Holzweißig;     Phone: [03643 2468-123 (Büro Weimar)];     Email: claudia.holzweiszig@ng-akademie.de
Topics
Gesprächsreihe, NGA, Onkologie,
Related subject(s)
45.
 
Hämato/Onko Refresher, Stuttgart
ID
786538
Dates
25 Nov 2016 - 26 Nov 2016
Location
GENO Haus Stuttgart, Heilbronner Str. 41, 70191 -, Germany
Contact
Christin Rasper;     Phone: [+49 (0) 6192 957 89 -41];     Email: info@fomf.de
Topics
Refresher, Hämatologie, Onkologie, Fortbildung
Related subject(s)
Event website
46.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773717
Dates
28 Nov 2016 - 02 Dec 2016
Location
Munich, Germany
Abstract
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
47.
 
Oncology Clinical Experience Programme
ID
792314
Dates
29 Nov 2016 - 01 Dec 2016
Location
Leeds, United Kingdom
Abstract
This clinical experience programme provides participants with an overview of the spectrum of malignant disease. The manifestation, presentation, investigation and management of a range of common solid tumour types (breast, lung, colorectal, gastrointestinal, melanoma, renal,) are reviewed. Clinicians active in these areas examine patient management throughout the process. Imaging techniques and radiotherapy treatment are explained and these departments visited. The context of cancer care is also reviewed, including the epidemiology of cancer and factors affecting treatment choices and prescribers' decision-making. This clinical experience programme combines taught lectures and clinical visits, providing a unique opportunity for delegates to experience, first hand, the assessment and treatment options utilised within the overall management of patients with malignant disease. Open discussions and case presentations form a key element of this programme. Additionally, delegates will have the opportunity to interact with patients and visit hospital departments in small group sessions.
Contact
Linda Merritt;     Phone: [01727 809917];     Email: courses@healthcare-ed.com
Topics
Introduction to oncology and the epidemiology of cancer, Overview of available therapies, current chemotherapy and radiotherapy practice, Breast, lung, colorectal, gastrointestinal, renal cancers and melanoma, New therapeutic options in oncology including immunotherapies, Department visits: radiotherapy and chemotherapy suites, outpatient clinics and radiology department
48.
 
Cancer Care – 2016 — International Conference on Cancer care and cure
ID
817976
Dates
01 Dec 2016 - 02 Dec 2016
Location
Dubai, United Arab Emirates
Abstract
International conference on cancer care and cure (Cancer care - 2016), a two day event from 01 - 02 December 2016, hosted and organized by Clyto Access Inc. with the theme - “Cancer: Emergence and Advancements”. The conference provides a platform to discuss cutting edge research to accelerate implementation of innovations into cancer research and clinical practices, featuring a wide range of topics, defining the most promising approaches towards cancer. The conference is designed to maximize interaction between participants, to engender creativity and cross-fertilization of ideas across multiple disciplines while fostering mentorship of early career scientists. We also encourage students by providing them an opportunity for poster presentations and awarding the best poster from all the participants. This conference has been expanded to include educational sessions and scientific abstract presentations as well.
Contact
Dhwani Hissaria;     Phone: [1-646-202-2876];     Email: cancercare2016@clytoaccess.com
49.
 
17th World Conference on Lung Cancer 2016
ID
649357
Dates
04 Dec 2016 - 07 Dec 2016
Location
Vienna, Austria
Abstract
The World Conference on Lung Cancer (WCLC) is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More than 7,000 delegates come from more than 100 countries to discuss the latest developments in thoracic malignancy research. Attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. 
Related subject(s)
50.
 
Nutrition and Cancer Care: What Patients want to know
ID
805216
Start date
07 Dec 2016
Location
South Kensington, London, United Kingdom
Abstract
The study day is aimed at dietitians, nurses doctors and other health care professionals working with cancer patients. Training conferences are created for professionals. If you are a patient and require information on Nutrition and Cancer, please consult your Clinical Nurse Specialist for more information or a referral to a Dietitian.

Aim: There is a wealth of information on diet and cancer – not all of it based on good scientific evidence. This study day will aim to look at popular areas of nutrition and cancer and untangle the myths from the evidence. It will focus on topics frequently raised by those with cancer.

Contact
Conference Team;     Phone: [020 7808 2924 / 21];     Email: conferenceteam@rmh.nhs.uk
Topics
Introduction – what people do and why. Did my diet cause my cancer?, What weight should I be during and after treatment? What is the role of exercise?, Do I need to avoid sugar?, I have been told to avoid dairy – is this right?, Should I exclude meat in my diet? Should I eat organic food?, Should I take a vitamin supplement?, Can I take herbal or homeopathic supplements?, Should I take probiotics?, Which superfoods should I have?, Should I follow an acid/ alkaline diet?
51.
 
Cell Symposia: Hallmarks of Cancer
ID
761504
Dates
11 Dec 2016 - 13 Dec 2016
Location
Ghent, Belgium
Abstract
As one of the most investigated areas in biomedical research, the cancer field is rapidly advancing by translating biological insights towards better detection and therapeutics, including molecular classifications as well as immunotherapies. In the era of the genetically informed, emerging concepts in cancer biology and oncology research are colliding into precision medicine. In order to accelerate the development of personalized cancer therapies and further translate fundamental discoveries into the clinic, there must be open lines of communication at the interface between the lab and the clinic. Our goal in organizing this Cell Symposium, Hallmarks of Cancer, is to convene global leaders in the cancer research arena to enhance our understanding of the key aspects of cancer and how to promote translation of this knowledge into the development of targeted therapeutics. We aim to provide a high-impact, high-profile forum for exchanging ideas and establishing a dialogue amongst clinicians, scientists and drug development companies. Symposium themes: Tumor metabolism, Tumor heterogeneity, Tumor immunology and immunotherapy, Personalized cancer therapy, Metastasis and the tumor microenvironment.
Related subject(s)
52.
 
2nd Symposium on “Advances in Cancer Immunology and Immunotherapy”
ID
829810
Dates
15 Dec 2016 - 17 Dec 2016
Location
Athens, Greece
Abstract
The field of tumor immunology and immunotherapy has entered a new era and our expanding knowledge of immune regulation has already led to innovative therapies for the treatment of cancer. The Symposium aims to bring together clinical and translational oncologists and immunologists to present most recent cutting-edge advances in the stimulating field of cancer immunotherapy. Distinguished invited speakers from leading Institutions in Europe and overseas will report on novel immunotherapeutic strategies leading to effective clinical responses, highlight the significance of prognostic and predictive cancer biomarkers in determining clinical outcome, analyse the principles of cancer immune surveillance and immune suppression, and exploit the potency of combinatorial treatments that can eventually contribute to promising anti-cancer therapeutic interventions. We aim to bring together researchers and clinicians working in these areas, promote interactions between speakers and participants, encourage stimulating discussions, exchange of ideas and experiences, and facilitate the establishment of contacts for new collaborations. In particular, young researchers will be offered the opportunity to present their work to an audience of eminent scientists and receive feedback that will impact on their scientific development in the fields of cancer immunology and immunotherapy.
Topics
Hellenic-immunooncology, immunooncology, Greece, Immunology, Immunotherapy, cancer
53.
 
IOPBS2016 — The 6th International Oncoplastic Breast Surgery Symposium 2016
ID
812629
Dates
16 Dec 2016 - 18 Dec 2016
Location
Bangkok, Thailand
Abstract
The congress is being jointly organized by The Thailand Section of the International College of Surgeons (ICS), Society of Plastic and Reconstructive Surgeons of Thailand, Thai Breast disease Society (TBS) and Siriraj Training and Education Center for Clinical Skills [SiTEC]. The past five congresses on International Oncoplastic Breast Surgery Symposium were successful with your support from all corners of the world. The 1st IOPBS in Seoul, Korea, the 2nd IOPBS in Daegu, Korea, the 3rd IOPBS in Tokyo, Japan, the 4th IOPBS in Taipe, Taiwan and the 5th IOPBS in Guangzhou, China.

In addition to the advanced knowledge and insight about the breast cancer diagnosis and treatment, the conference will lay stress on the importance of essential oncologic concept along with integrity of reconstructive surgery. In order to reduce the physical mutilation and improve quality of life, the individualization of oncoplastic surgery principle can be applied to breast cancer patient care. The worldwide list of expert includes the breast cancer experts of oncologic surgery, reconstructive surgery and multidisciplinary team are willing to share their latest findings and valued experience. We believe that it will be an extraordinary academic event with your honorable participation.

Contact
Secretariat office;     Phone: [66817018345];     Email: iopbs.congress@gmail.com
Topics
Oncology, plastic surgery, oncoplastic surgery, breast cancer
Related subject(s)
Event website
54.
 
ESMO ASIA 2016 Congress
ID
799958
Dates
16 Dec 2016 - 19 Dec 2016
Location
Singapore, Singapore
Abstract
This scientific and educational congress is led by an international scientific committee and promotes the sharing of expertise and interaction between regional and international experts in oncology. The programme will offer state of the art science and the current standard of care across all major tumour types.
55.
 
Keystone Symposia: Cell Plasticity within the Tumor Microenvironment
ID
828579
Dates
08 Jan 2017 - 12 Jan 2017
Location
Big Sky, Montana, United States
Abstract
Scholarship & Discounted Abstract Deadline: Sep 13, 2016; Abstract Deadline: Oct 6, 2016; Discounted Registration Deadline: Nov 8, 2016

During the last decade, it has become unequivocally evident that tumor development is not a cell-autonomous process but rather depends on the intricate reciprocal interplay of mutant tumor cells with their local and distant environments. Composition and polarization of cells in the tumor microenvironment depends on genetic as well as environmental factors and is directly influenced by tumor therapy. Indeed, therapies that aim to shape the local immune milieu and consecutive signaling pathways in both stromal and tumor/stem cells address the complex pathophysiology of tumors more adequately and may therefore add substantial benefits for therapy. An absolute pre-requisite for such an endeavor is a comprehensive understanding of the exact molecular basis of the complex signaling networks in the tumor microenvironment that control the plasticity of both stromal and tumor cells, thereby shaping the complex cellular contexture, which ultimately forms a pro- or anti-tumorigenic milieu. Thus, this symposium aims to gather a comprehensive functional understanding of mediator-dependent cellular and molecular events that are responsible for the plasticity of both stromal and tumor/stem cells. It will bring together experts in cancer, stromal and immune cells to synthesize scientific knowledge about the phenomenon of cell plasticity within the tumor microenvironment, to define molecular and cellular pathways mediating plasticity and to propose approaches to interfere with cell plasticity for a new generation of effective therapeutic approaches in cancer and chronic injury. Importantly, it will bring together interdisciplinary groups of scientists or investigators who normally would not have an opportunity to meet (classical cancer biologists, tumor immunobiologists, stem cell experts and scientists working on stromal cells).

Contact
Attendee Services;     Phone: [970-262-1230];     Email: info@keystonesymposia.org
Topics
Cancer, tumor immunology, basic mechanisms
Related subject(s)
56.
 
Keystone Symposia: TGF-ß in Immunity, Inflammation and Cancer
ID
828577
Dates
09 Jan 2017 - 13 Jan 2017
Location
Taos, New Mexico, United States
Abstract
TGF-beta is a key regulator of immune responses, inflammation and cancer. In addition to the well-established effects of TGF-beta on CD4+ T cell differentiation and reprogramming, TGF-beta also plays critical roles in other immune cells. TGF-beta has also been implicated in the regulation of the interactions among immune cells, microbiota and epithelial cells. In addition to safeguarding immune homeostasis and suppressing chronic inflammation and autoimmunity, TGF-beta is emerging as a potential checkpoint in anti-tumor immunity. Despite great progress in the field, key questions related to TGF-beta functions in immune responses are still largely undetermined. Therefore, it is imperative to understand the cellular and molecular mechanisms by which TGF-beta controls such diverse immune cells. Elucidation of these pathways would allow us to understand the pathogenesis of chronic inflammation, autoimmunity and cancer and aid development of therapeutic practices in experimental and ultimately clinical settings. This meeting will gather together experts in the fields of both TGF-beta signaling and immunology to discuss new findings and update the pivotal role of TGF-beta in immunity, inflammation and cancer, with the aim to lay out the critical and key questions and outline new directions.
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
cytokines, immunology, inflammation, tumor immunology, t-cell biology, cancer
Related subject(s)
57.
 
Keystone Symposia: PI3K Pathways in Immunology, Growth Disorders and Cancer
ID
829963
Dates
19 Jan 2017 - 23 Jan 2017
Location
Santa Fe, United States
Abstract
The overall goal for this meeting is to bring together scientific leaders and trainees with a common interest in PI3Ks and relevant downstream physiological processes. It will address advances in basic molecular and cellular mechanisms that are regulated by PI3Ks, other PI kinases and, their cognate phosphatases; highlight new advances in the characterization of PI3K pathway alterations in genetic syndromes that affect growth and the immune and nervous systems; and provide an important update on the clinical development of PI3K pathway inhibitors, and implications for the burgeoning field of cancer immunotherapy. Whole exome sequencing studies have increasingly implicated PI3K signaling in diseases (immune, growth and neurological disorders) which may benefit from drugs currently in development for cancer and inflammation. This meeting will be an important forum for discussing approaches to treating these additional disorders.
Contact
Attendee Services;     Phone: [970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Immunology, cancer, biochemistry
58.
 
ECCO2017 — European Cancer Congress 2017
ID
806266
Dates
27 Jan 2017 - 30 Jan 2017
Location
Amsterdam, Netherlands
Abstract
The European Cancer Congress is the multidisciplinary evidence based meeting for all cancer types, addressing all oncology disciplines and related healthcare professions. ECCO2017 will have a direct impact on daily clinical practice. Focusing on phase III data, this scientific meeting will put the new evidence into perspective for a multidisciplinary audience by critically reviewing it in expert panels. Leading oncologists will address the value of these potentially practice changing treatments by reviewing their clinical benefits and cost. Experts, patient advocates and the audience will determine whether the data really do support changes in clinical practice.
Contact
Congress Secretariat;     Phone: [+32 (0)2 775 02 01];     Email: info@eccocongress.org
Topics
cancer, oncology, precision medicine, multidisciplinary, cancer congress,
59.
 
Keystone Symposia: Epigenetics and Human Disease – Progress from Mechanisms to Therapeutics
ID
833039
Dates
29 Jan 2017 - 02 Feb 2017
Location
Seattle, Washington, United States
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genetics, genomics, basic mechanisms, molecular biology, cancer
60.
 
Complementary Therapies — The Use of Essential Oils in a cancer Care Environment 2 Day Course
ID
806429
Dates
30 Jan 2017 - 31 Jan 2017
Location
South Kensington, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Audience: This two day introductory course is suited to aromatherapists who are already working with essential oils in a cancer care environment. Due to the structure of this course it is not possible to book for a single day. Aims:The purpose of this two day course is to promote discussion, link essential oil research to sound and effective practice and to improve aromatic interventions for people with cancer.
Related subject(s)
61.
 
Clinical Aromatherapy in End of Life Care — Aromatic Support in the dying process
ID
806408
Start date
01 Feb 2017
Location
South Kensington, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Topics include:The dynamics of the dying process / The signs and symptoms that death is approaching Key issues include working with:Reduced state of consciousness, Disorientation, Restlessness, terminal agitation, Mouth dryness, Circulatory changes, Malodour due to incontinence, wounds, Chest congestion, increased oropharyngeal secretions, Breathing pattern changes, Pain, Key essential oils for the dying phase, Creating a supportive aromatic environment, Aromatic support for the family, Aromatherapy limitations and contraindications,
62.
 
Pain Management — The Use of Essential Oils for Pain Management
ID
806439
Start date
02 Feb 2017
Location
South Kensington, London, United Kingdom
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Aims and Objectives: Taking a whole person approach and linking this to a strong evidence base, delegates will increase their knowledge, skills and confidence in using essential oils safely and effectively with individuals in pain. Specific essential oils with good evidence for their pain relieving effects will also be profiled in this study day.
63.
 
EMBL-Cancer Core Europe Conference: Cancer Immunotherapy
ID
818071
Dates
02 Feb 2017 - 04 Feb 2017
Location
Heidelberg, Germany
Abstract
The 2017 EMBL-Cancer Core Europe Conference on Cancer Immunotherapy will cover highly relevant sub-disciplines of cancer immunology with a special focus on personalised immunotherapy.

The European Molecular Biology Laboratory (EMBL) and Cancer Core Europe - a consortium of Europe's 6 leading Comprehensive Cancer Centers (Gustave Roussy Cancer Campus Grand Paris, France; Cambridge Cancer Centre, United Kingdom; Karolinska Institutet, Sweden; Netherlands Cancer Institute (NKI), Vall d’Hebron Institute of Oncology, Spain and the German Cancer Research Centre (DKFZ) with it's National Center for Tumour Diseases (NCT) Heidelberg) - are proud to join forces to host the first EMBL-Cancer Core Europe Conference on Cancer Immunotherapy.

Contact
EMBL Marketing;     Phone: [4962213878797];     Email: marketing@embl.de
Topics
cancer, immunotherapy, tumour microenvironment
64.
 
Respiratory Conditions — Essential Oils for Respiratory Conditions
ID
806394
Start date
03 Feb 2017
Location
South Kensington, London, United Kingdom
Topics
Taking an evidence-based approach we shall explore: an overview of the respiratory system, specific essential oil and component actions that are relevant including: secretolytic, secretomotor, bronchospasmolytic, mucolytic, calming, antitussive and antimicrobial, key aromatherapy applications for respiratory care (inhalers, inhalation devices, diffusion, chest rubs, massage, aroma patches, allied techniques), a spotlight on eight essential oils that have particular value in this area, holistic and clinical approaches to breathlessness, aromatherapy as a part of a multidisciplinary approach to managing breathlessness, safety issues including risk of bronchospasm, debate about essential oils and oxygen therapy and appropriate dosing.
Related subject(s)
65.
 
Keystone Symposia: Noncoding RNAs – From Disease to Targeted Therapeutics
ID
833372
Dates
05 Feb 2017 - 09 Feb 2017
Location
Banff, Alberta, Canada
Abstract
It has become apparent over the last decade that small and long noncoding RNAs play a major role in the regulation of gene expression and disease. While much emphasis has been centered on the role of noncoding RNAs in human disease, a gap remains in utilizing this knowledge to develop target specific approaches to disrupting noncoding RNA pathways for therapeutic gain. This meeting will for the first time bring together an interdisciplinary group of basic and applied noncoding RNA scientists in an effort to translate our current understanding of noncoding RNA biology into meaningful therapeutics for many of those diseases afflicting society. To accomplish this goal, the meeting will aim to: (1) Introduce the broad genome-wide basic fabric of noncoding RNA regulation and form and function in the cell; (2) Focus on direct RNA/chromatin/DNA or RNA/protein interactions with candidate disease-relevant model systems; and (3) Highlight synthetic biological approaches to developing RNA or oligonucleotide mimics to target and/or disrupt particular disease-relevant noncoding RNA pathways. The goal of this meeting is to bring together basic and applied scientists working on noncoding RNAs in an effort to not only better understand the role noncoding RNAs play in the regulation of disease-relevant genes but also the emerging ability to utilize this knowledge to develop targeted therapeutics, an eventuality that heralds a new frontier in drug development and therapeutics.
Contact
Attendee Services;     Phone: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Topics
genetics, genomics, RNA, molecular biology, transcription
66.
 
PRIMO — 2017 Practical Considerations in Immuno and Molecular Oncology (PRIMO) Annual Meeting
ID
807208
Dates
09 Feb 2017 - 12 Feb 2017
Location
Maui, United States
Abstract
The Practical Considerations in Immuno and Molecular Oncology (PRIMO) Meeting is an annual CME-certified conference to help practicing providers keep up with the latest advances in immuno and molecular targeted therapies. This year’s meeting is scheduled to take place February 9-12, 2017 in Wailea Beach, Maui, Hawaii and will help providers address real world issues on how and when to optimally integrate these new therapies into their clinical practice, and also provide insight into new advances in immune and molecular targeted therapies that are expected to report new data in 2017.The PRIMO Meeting is for those who want a streamlined review of the most recent advances in immuno and molecular oncology delivered by some of the top experts in their respective field. This meeting is for practicing oncologists, hematologists, research fellows, and nurses. Interested parties can log on to www.primomeeting.org for more information.
Contact
Jen Mahon;     Phone: [1-855-677-4668];     Email: info@primomeeting.org
Topics
oncology, continuing medical education, immunotherapy
67.
 
Neuro Oncology — Paediatric Neuro-Oncology Study Day
ID
806469
Start date
13 Feb 2017
Location
South Kensington, London, United Kingdom
Abstract
Aim: The day will update practitioners on current practice in managing this patient group and where possible the evidence base to inform practice. It will raise awareness of issues specifically related to children’s palliative care.
Contact
Conference Team;     Phone: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Topics
Topics to include: Overview of childhood brain tumours, Treatment options available currently / new treatments on horizon, Neurosurgical options, Use of Radiotherapy, Nursing case study, Supporting children with play therapy, Psychological considerations, Neuro rehabilitation Patient experience,
Related subject(s)
68.
 
APBCS — 6th Asia-Pacific Breast Cancer Summit
ID
832761
Dates
17 Feb 2017 - 19 Feb 2017
Location
Hong Kong, China
Abstract
Being one of the most common cancers in women, both in developed and underdeveloped regions of the world, there is a need to discuss the latest aspects of breast cancer and its alarming increase. During the past four years, the Asia Pacific Breast Cancer Summit has been successfully addressing vital topics regarding this prevalent disease.

In 2017, the 6th Asia Pacific Breast Cancer Summit will once again to bring together international & regional faculty experts in breast cancer to cover surgical, radiation and medical oncology related topics on early and advanced breast cancer management.

Contact
Tripti Vachher;     Phone: [+97143116300];     Email: breastsummit@mci-group.com
Topics
Cancer, Breast cancer
Related subject(s)
69.
 
2nd Annual Immuno-Oncology Summit Europe
ID
829793
Dates
20 Feb 2017 - 24 Feb 2017
Location
London, United Kingdom
Abstract
Following the success of the 2016 conference in London, we present the Immuno-Oncology Summit Europe 2017. Once again our venue is in central London, an ideal meeting place for international academic and industry experts. Attendees can now experience an entire week of updates and discussion. In Novel Approaches for Cancer we will focus on T cells and their receptors including chimeric antigen receptor (CAR-T) technology, bispecifics, preclinical models, and targets and lead selection. Immunomodulatory Approaches will look at advances in checkpoint inhibitors, agonistic receptor engagement, NK, macrophage and dendritic cell activation, Fc-engineering technologies, cytokine-based therapies and oncolytic vaccines. Combination Immunotherapy will examine design of immunotherapy combinations, combination strategies and provide preclinical and clinical updates.
Contact
Jaime Hodges;     Phone: [781-972-5400];     Email: chi@healthtech.com
70.
 
IGSHNO — Indo Global summit of Head & Neck Oncology
ID
824488
Dates
24 Feb 2017 - 26 Feb 2017
Location
Jaipur, Rajasthan, INDIA, India
Contact
Dr Anil K Gupta;     Phone: [+91-9829052417];     Email: igshno2017@gmail.com
Topics
Indo- Global Summit on Head & Neck Oncology (IGSHNO), BMCON-IV, Multidisciplinary Approach – Expanding Treatment Horizons, Head & Neck Cancer, Oncosurgery, Onco-plastic surgery, Medical Oncology, Radiation Oncology, ENT, Dental (Maxillofacial, Prosthodontics etc.), Palliative care and Rehabilitation, Cancer Prevention, Cancer psychology, chnological advances and innovation
71.
 
Cancer Conference
ID
781837
Dates
24 Feb 2017 - 27 Feb 2017
Location
Carlsbad, United States
72.
 
Frontiers in Cancer Immunotherapy
ID
824447
Dates
27 Feb 2017 - 28 Feb 2017
Location
New York, NY, United States
Abstract
This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. James Allison, Executive Director of the Immunotherapy Platform at the University of Texas MD Anderson Cancer Center and a pioneer in the field of cancer immunotherapy, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.
Topics
Immunotherapy, Oncology, Immunology, Therapeutics, Clinical Trials, Vaccines, Diagnostics, Biomarkers, Genomics, Epigenomics, Epigenetics, Drug Discovery, Cancer
73.
 
2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference
ID
813987
Dates
27 Feb 2017 - 02 Mar 2017
Location
Cancun, Mexico
Abstract
Defect in DNA damage repair and checkpoint control is the underlying mechanism for tumorigenesis, since it allows the accumulation of multiple genetic alternations, which are essential for the initiation of tumorigenesis. This has been clearly illustrated to be the cause of several human cancer-prone syndromes and also revealed by recent human genome studies. On the other hand, defective DNA repair and checkpoint activation also make cancer cells more vulnerable for particular DNA damaging agents or inhibitors that specifically disrupt some of these checkpoint pathways. With the increasing understanding of defects in DNA repair and checkpoint control in tumorigenesis, there are extensive interests in exploring these deficiencies, especially taking advantage of the synthetic lethality concept and targeting particular DNA repair and checkpoint pathways for cancer therapy. The purpose of this conference is to bring together basic, translational and clinical investigators and discuss the current and future directions, opportunities and obstacles in the development of these anti-cancer modalities and how to best apply these concepts in clinical practice.
Contact
Jack Peters;     Email: jack@fusion-conferences.com
Topics
Cancer, Cancer Therapy, DNA
74.
 
AEK — 19th International AEK Cancer Congress
ID
811326
Dates
01 Mar 2017 - 03 Mar 2017
Location
Heidelberg, Germany
Related subject(s)
75.
 
Keystone Symposia - Adaptations to Hypoxia in Physiology and Disease
ID
825239
Dates
05 Mar 2017 - 09 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
Cellular responses to changes in oxygen availability have important implications for both physiology and pathophysiology, in particular in the setting of solid tumor progression. A number of hypoxia-inducible pathways have been characterized, such as the large transcriptome regulated by hypoxia-inducible factors (HIFs). However, many other oxygen-sensing pathways exist within the cell. The aim of this meeting is to disseminate up-to-date information on basic mechanisms of cellular and tissue hypoxia responses, and discuss the impact of these responses on physiology and cancer, with an emphasis on HIF-independent, but nevertheless fundamental, oxygen-sensing pathways. Outcomes of this meeting will include the dissemination of new scientific knowledge, the discussion of new methodologies, the education of graduate students and postdoctoral fellows in this discipline, and promotion of new collaborations between clinicians, basic researchers and industrial partners. This will be the eighth Keystone Symposia meeting on Hypoxia, which brings together academic, clinical and industrial researchers to enhance synergy between these groups and develop translational strategies for targeting hypoxic stress responses for therapeutic benefit.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
hypoxia, tumor metabolism, hypoxic influences, intracellular homeostasis, tumor microenvironment, tumor stroma, tumor progression, o2 availability, stress responses
Related subject(s)
76.
 
Keystone Symposia - Tumor Metabolism: Mechanisms and Targets
ID
825212
Dates
05 Mar 2017 - 09 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
This conference is on the rapidly moving field of tumor metabolism and its implications in cancer development, progression and therapy. Experts from distinct fields of research will be brought together to present their latest discoveries on tumor metabolism, which is an inherently interdisciplinary field. Defining the diversity of metabolic strategies employed by cancer cells and how the genetic events underlying different types of cancer, as well as the tumor microenvironment, influence these metabolic properties is a major goal of this meeting. In addition, a combination of basic, translational and clinical studies will be presented, with the goal of identifying promising avenues in tumor metabolism that impact our understanding, diagnosis and treatment of cancer. In addition to a stellar line up of invited speakers, short talks and poster presentations will provide opportunities for researchers at all levels to discuss their most current work in this field. This meeting provides an excellent opportunity to share knowledge and methodology in tumor metabolism research in a collegial and social atmosphere.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
tumor metabolism, hypoxia, oncogenic control, metabolic strategies, metabolic adaptions, metabolic vulnerabilities, tumor progression, tumor supression
77.
 
APCCC 2017 — Advanced Prostate Cancer Consensus Conference (APCCC) 2017
ID
801141
Dates
09 Mar 2017 - 11 Mar 2017
Location
St. Gallen, Switzerland
Abstract
In advanced prostate cancer, rapid and successful drug development has resulted in multiple treatment options, requiring careful decision making for individual patients. Clinicians face the increasingly difficult task of choosing from multiple potentially effective treatments that are also costly and potentially toxic. The inaugural Advanced Prostate Cancer Consensus Conference (APCCC) did provide a forum for discussion and debates on current treatment options for men with advanced prostate cancer. The conference concluded with voting by the panel on pre-defined consensus questions, targeting areas of primary clinical relevance. Following the conference a manuscript with containing the expert recommendations was published at Annals of Oncology.
Related subject(s)
Event website
78.
 
ICTO2017 — International Congress on Clinical Trials in Oncology and Hemato-Oncology
ID
819977
Dates
16 Mar 2017 - 17 Mar 2017
Location
London, United Kingdom
Contact
Debi Bert;     Email: debi@bioevents.net
Topics
Oncology, Hemato-Oncology, Clinical Trials
Related subject(s)
Event website
79.
 
Keystone Symposia - Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
ID
825252
Dates
19 Mar 2017 - 23 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
The fields of cancer immunology and immunotherapy continue to make great strides in providing both a comprehensive understanding of the basic mechanisms underlying tumor-immune system interactions and applying this knowledge to the development of effective immune-based cancer therapies. This Keystone Symposia meeting is organized to highlight recent insights into the complex roles of immune components and pathways in controlling or alternatively promoting cancer and to showcase recent uses of cancer vaccines, checkpoint blocking strategies, adoptive cell therapies and cellular engineering approaches, either as mono- or combinatorial therapies, that have resulted in durable, effective and safe therapeutic responses to an increasing number of cancer patients. Part of the meeting will also focus on new, developing technologies that are likely to expand our capacity to monitor the effects of cancer immunotherapy with a precision, refinement and at a level that has not been possible in the past.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
cancer immunology, cancer immunotherapy, immunosuppressive cells, tumor microenvironment, immune checkpoints, combinatorial approaches, cancer vaccines, inflammation, cellular engineering, nex-gen technologies
80.
 
Keystone Symposia - Immune Regulation in Autoimmunity and Cancer
ID
825369
Dates
26 Mar 2017 - 30 Mar 2017
Location
Whistler, British Columbia, Canada
Abstract
While the importance of adoptive and innate immunity has been clear in the pathogenesis of human autoimmune disease resulting in a multitude of immune-based therapeutic approaches, the realization is now apparent that understanding immune evasion by cancer is central in developing curative treatments. This meeting will explore and contrast the underlying immune mechanisms resulting in autoimmunity and tumor evasion. The meeting is innovative in bringing together basic immunologists investigating mechanisms of tolerance with scientists exploring immune mechanisms of autoimmunity and cancer in both patients and experimental models. Thus, this Keystone Symposia meeting will cover the pathways in immunity and tolerance that lead to loss of immunological control, dysregulated immune responses and chronic inflammatory disease or tumor evasion. Presentations will include consideration of preclinical and clinical aspects of a diverse number of autoimmune and inflammatory diseases and cancer. Conference participants engaged in preclinical, translational and clinical research will hopefully engage in continuing conversations and collaborations which, over the long-term, will provide greater insights into the human immune response and allow us to reassess and further explore pathways that are driving autoimmune disease yet in opposition, lead to tumor evasion. Understanding checkpoints in autoimmunity and immune cell tolerance is important for delivering therapies to patients with autoimmune disease and cancer, and this meeting will provide a platform for the cross-pollination of clinical experience and experimental research. Attendees will have learned about the impact of targeted immune-based therapeutics on clinical outcome and, consequently, be able to widen their research scope accordingly.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Immune Regulation, Autoimmunity, Cancer, Tissue Micro-Immune Environments, Autoimmune Tissue Inflammation, T Cell Tolerance, Effector T Cell Dysfunction, Innate Regulation, B Cell Regulation, Th17 Cell
Related subject(s)
81.
 
Keystone Symposia - Genomic Instability and DNA Repair
ID
825260
Dates
02 Apr 2017 - 02 Jun 2017
Location
Santa Fe, New Mexico, United States
Abstract
Genome stability is the foundation upon which all cellular and organismal processes depend. This conference will grapple with the intricate array of biochemical reactions orchestrated by the cell to replicate, repair and segregate chromosomes accurately despite constant threats from spontaneous and environmentally-induced damage. Defects in these reactions lead to genomic instability, a confirmed driver of cancer and degenerative diseases. Fascinating and therapeutically crucial questions remain about the mechanisms underlying chromosome stability, and cross-disciplinary approaches are required to address them. How do epigenetic chromatin marks influence repair of underlying DNA sequences, and how can we predict the effects of chemotherapeutic agents that alter such marks? To what extent is the nucleus organized into subdomains with distinct functions; how are these subdomains altered when cells move or differentiate? How are the myriad helicases, nucleases and polymerases coordinated to safeguard genome stability, why are these molecules often mutated in human disease, and how can we ameliorate the effects of such mutations? What is the array of strategies available to cancer cells as they achieve unlimited proliferation? This conference has a history of bringing together investigators from diverse subfields who otherwise rarely meet. Cutting-edge concepts in translational, genomic, cellular, molecular, RNA and structural biology will be dissected to take the conversation to unprecedented levels of depth and breadth. The concurrent conference on “DNA Replication and Recombination” will provide additional opportunities for cross-talk. Both conferences are committed to nurturing interactions among longtime experts in the field with students, postdocs and investigators new to the field.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genomic Instability, DNA Repair, RNA Metabolism, Chromatin Structure, DNA Replication/Repair, Nuclear Dynamics, Cell Cycle Regulation, DNA Damage Response, Replication Coupled Repair, Telomeres, Centromeres
Related subject(s)
82.
 
CancerMetastasis — Cancer Metastasis through the Lymphovascular System: Biology & Treatement, 7th International Symposium
ID
813081
Dates
20 Apr 2017 - 22 Apr 2017
Location
San Francisco, United States
Abstract
This is a very exciting time to be involved in cancer research! The 7th iteration of the Symposium brings together international experts in oncology, immunobiology, pharmacology, molecular biology and molecular imaging to discuss preclinical, translational and clinical advances in diagnosing, treating and preventing cancer metastasis as we enter the era of precision medicine. With advancements in cancer care and patient-centered treatment planning, cancer survivors today live longer and enjoy a vastly improved quality of life than thought imaginable. We hope you will participate in Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium, scheduled for April 20-22, 2017 in San Francisco, California.
Contact
Joan Oefner;     Phone: [491711049181];     Email: joefner@cancermetastasis.org
Topics
immunotherapy, oncology, breast cancer, melanoma, lymphedema, radiation therapy, metastasis, cancer biology, cancer treatment, cancer microenvironment, tumor, Lymphatic System, molecular biomarkers, Sentinel Lymph Nodes
83.
 
iwCLL — XVII International Workshop on Chronic Lymphocytic Leukemia
ID
823304
Dates
12 May 2017 - 15 May 2017
Location
New York City, United States
Abstract
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biannual meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to these blood cancers, leading the scientific discussion on both laboratory-based research and clinical practice. The biannual meeting provides a forum that facilitates the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and other lymphoproliferative disorders.
Contact
Kraig Steubing;     Phone: [1-888-476-9129];     Email: iwcll2017@bioascend.com
Topics
CLL, Lymphoproliferative Disorders
Related subject(s)
84.
 
American Society of Clinical Oncology 2017 Annual Meeting
ID
651333
Dates
02 Jun 2017 - 06 Jun 2017
Location
Chicago, United States
Abstract
Attendees of the 2017 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
Event website
85.
 
2nd DNA Replication as a Source of DNA Damage Conference
ID
814148
Dates
03 Jul 2017 - 06 Jul 2017
Location
Rome, Italy
Abstract
The maintenance of genome integrity is critical for the suppression of cancer and premature ageing. Only recently has it become appreciated that DNA replication stress is a crucial driver of genomic instability. The timely progression of replisomes can be disrupted by lesions and secondary structures in the template, by bound proteins and by conflicts with the transcription machinery. A prolonged pause of the replisome then exposes single stranded DNA, which, due to its recombinogenic nature, can lead to genome rearrangements, fragile site expression and cell death. Importantly, some cancers present excessive endogenous levels of replication stress, which can be exploited for their clearance. In this conference, we aim to bring together scientists studying DNA replication and repair, with those interested in how DNA damage can influence cancer and ageing.
Contact
Laura Trundle;     Email: laura@fusion-conferences.com
Topics
DNA Replication, DNA Damage, Cancer, Ageing
Related subject(s)
86.
 
ESMO 2017 Congress
ID
799872
Dates
08 Sep 2017 - 12 Sep 2017
Location
Madrid, Spain
Abstract
“Integrating science into oncology for a better patient outcome.” In an era of deep understanding of the molecular biology underlying the development of cancer, it is crucial that researchers and clinicians exchange knowledge. The ESMO 2017 Congress, in partnership with EACR, will bring oncology professionals together to facilitate interaction and bridge knowledge sharing between the laboratory and clinic. The aim of ESMO 2017 is to work together, aligning the objectives of researchers and clinicians, in order to provide more precise direction leading to better treatment options for cancer patients. The ESMO Congress is  the  most influential annual meeting for oncology professionals in Europe. We invite you to save the date.
87.
 
7th InterAmerican Oncology Conference
ID
814156
Dates
05 Oct 2017 - 06 Oct 2017
Location
Buenos Aires, Argentina
Abstract
The 7th. InterAmerican Oncology Conference "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 5th and 6th, 2017.

An outstanding faculty of speakers from the United States and Europe has committed in this meeting.

The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.

Contact
Email: oncology@oncologyconferences.com.ar
Topics
New Anticancer Therapies, Novel Agents in Early Clinical Trials, Melanoma, Breast Cancer, Immunotherapies, Biomarkers for Checkpoint Inhibitors, Genitourinary Cancer, Prostate cancer, Metastatic Renal Cell Carcinoma, Bladder Cancer, Gastrointestinal Cancer, Gastric Cancer, Colorectal cancer, Lung cancer, Mesothelioma, Hematological Malignancies, Leukemia, Multiple Myeloma, Lymphoma
Related subject(s)
88.
 
TBCC9 — The International Tehran Breast Cancer Congress
ID
830824
Dates
18 Oct 2017 - 20 Oct 2017
Location
TEHRAN, Iran
Abstract
The International Tehran Breast Cancer Congress (ITBCC) provides a unique multidisciplinary setting for all professionals with a common interest in breast cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape; to debate and deliberate about new data and developments; and to establish what it means for patient treatment and care.

Leading international and national scientists and physicians will address recent advances in breast cancer research, personalized therapy, and the latest clinical data impacting the treatment of breast cancer. Cutting-edge lectures, panel discussions, and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with pioneers as they share their perspectives and personal experiences on the challenges and ongoing controversies in breast cancer.T

Contact
Secretariat;     Phone: [+9821-88673129];     Email: CONGRESS@IBCRC.IR
Topics
New concepts in Breast Cancer ; ( Epidemiology, Oncoplatic surgery & reconstruction, Screening & Prevention, Neoadjuvant & Adjuvant therapy, Radiotherapy, Imaging, Genetics & Heredity, Immunotherapy & Cell Therapy, Pathology, Quality of life, Ethical aspects, Medical informatics, Fertility preservation & Tissue engineering)
Related subject(s)
89.
 
Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research
ID
764413
Dates
18 Oct 2017 - 21 Oct 2017
Location
Brisbane, Australia
Contact
Vivien Lietze;     Phone: [+4930204590];     Email: congress@worldmelanoma2017.com
Topics
Dermatology, Dermato-Oncology, Skin-Cancer, Melanoma
Related subject(s)
90.
 
ESGO 2017 Congress in Vienna — 20th Biennial International Meeting of the European Society of Gynaecological Oncology
ID
825933
Dates
04 Nov 2017 - 07 Nov 2017
Location
Vienna, Austria
Abstract
Held biennially, ESGO congress offers professionals in Gynaecological Oncology - including clinicians, researchers, residents and students a unique opportunity to learn and discuss the latest medical and scientific developments in gynaecological cancers research, treatment and care, as well as to network with key opinion leaders and peers from around the world.
Contact
Lucie Lamlova;     Email: lucie.lamlova@esgomail.org
Topics
the latest medical and scientific development, gynaecological cancers research, treatment and care
Related subject(s)
91.
 
EMBL Conference: Cancer Genomics
ID
834578
Dates
05 Nov 2017 - 08 Nov 2017
Location
Heidelberg, Germany
Abstract
This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2015 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Contact
Phone: [4962213878797];     Email: marketing@embl.de
Related subject(s)
92.
 
ICC2017 — 2nd Indian Cancer Congress
ID
833873
Dates
08 Nov 2017 - 12 Nov 2017
Location
BANGALORE, India
Abstract
The Indian Cancer congress is an amalgamation of the four major national oncology associations ( The Association of Radiation Oncologists of India, Indian Association of Surgical Oncology, the Indian Society of Medical & Pediatric Oncologists and the Indian Society of Oncology) . This conference is a planned quadrennial event of these four associations and all other sub specialty associations to improve the quality of cancer care through multidisciplinary interactionand will be held in various parts of the Indian subcontinent once every four years. The ICC2017 conference is scheduled to be held from 9th to 12th November 2017 (with pre-conference workshop held on 8th Nov 2017) in Bengaluru, India.The theme for the conference is “INSIGHT, INNOVATION, INTEGRATION” The field of oncology is rapidly evolving and is in constant flux. What is thought to be true today may very soon be turned on its head by new insights and new innovations. It is therefore prudent and necessary that we the oncology community – periodically stop in our fast tracks and take stock of some important insights and innovations and debate how best we can integrate these innovations into our practice. The congress hopes to attract each and everyone involved in the care of the cancer patient including physicians, basic scientists, patients, survivors , care givers, researchers, investors etc and to provide a platform from which meaningful value addition can emerge.
Contact
Nalini Rao;     Phone: [9845517681];     Email: nkrao@hotmail.com
93.
 
Cancer Imaging and Therapy
ID
836373
Dates
02 Apr 2018 - 06 Apr 2018
Location
Hollywood, United States
Abstract
The Cancer Imaging and Therapy conference will focus on optical methods in cancer, centered on imaging and treatment of cancer. The conference will accept submissions on topics on the molecular and cellular level, such as reporters and theranostics; on the tissue and pre-clinical (animal) level, such as pathology methods and advances in imaging of tumor models; and on human tissue and living human subjects, when specifically dealing with cancer. More generic biomedical optics and biophotonics research involving human tissues or living human subjects should be submitted to the Clinical and Translational Biophotonics conference at this congress.

Good to know...

You can advertise your event or services in this space.

Last updated: 13 September 2016